|
1.
|
Bacci G, Briccoli A, Ferrari S, et al:
Neoadjuvant chemotherapy for osteosarcoma of the extremity:
long-term results of the Rizzoli’s 4th protocol. Eur J Cancer.
37:2030–2039. 2001.
|
|
2.
|
Bielack SS, Kempf-Bielack B, Delling G, et
al: Prognostic factors in high-grade osteosarcoma of the
extremities or trunk: an analysis of 1,702 patients treated on
neoadjuvant cooperative osteosarcoma study group protocols. J Clin
Oncol. 20:776–790. 2002.
|
|
3.
|
Paulussen M, Fröhlich B and Jürgens H:
Ewing tumour: incidence, prognosis and treatment options. Paediatr
Drugs. 3:899–913. 2001.
|
|
4.
|
Paulussen M, Ahrens S, Dunst J, et al:
Localized Ewing tumor of bone: final results of the cooperative
Ewing’s Sarcoma Study CESS 86. J Clin Oncol. 19:1818–1829.
2001.
|
|
5.
|
Rizzo M, Ghert MA, Harrelson JM and Scully
SP: Chondrosarcoma of bone: analysis of 108 cases and evaluation
for predictors of outcome. Clin Orthop Relat Res. 391:224–233.
2001.
|
|
6.
|
Welkerling H, Kratz S, Ewerbeck V and
Delling G: A reproducible and simple grading system for classical
chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas
with emphasis on recurrence rate and radiological and clinical
data. Virchows Arch. 443:725–733. 2003.
|
|
7.
|
Folkman J, Watson K, Ingber D and Hanahan
D: Induction of angiogenesis during the transition from hyperplasia
to neoplasia. Nature. 339:58–61. 1989.
|
|
8.
|
Hasan J, Byers R and Jayson GC:
Intra-tumoural microvessel density in human solid tumours. Br J
Cancer. 86:1566–1577. 2002.
|
|
9.
|
Kawaguchi N, Matumoto S and Manabe J: New
method of evaluating the surgical margin and safety margin for
musculoskeletal sarcoma, analysed on the basis of 457 surgical
cases. J Cancer Res Clin Oncol. 121:555–563. 1995.
|
|
10.
|
Huvos AG: Bone Tumors: Diagnosis,
Treatment, and Prognosis. 2nd edition. W.B. Saunders; Philadelphia:
pp. 85–155. 1991
|
|
11.
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991.
|
|
12.
|
Iwamoto Y, Tanaka K, Isu K, et al:
Multiinstitutional phase II study of neoadjuvant chemotherapy for
osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J. J Orthop
Sci. 14:397–404. 2009.
|
|
13.
|
Kimura H, Tsuchiya H, Shirai T, et al:
Caffeine-potentiated chemotherapy for metastatic osteosarcoma. J
Orthop Sci. 14:556–565. 2009.
|
|
14.
|
Mikulić D, Ilić I, Cepulić M, et al: Tumor
angiogenesis and outcome in osteosarcoma. Pediatr Hematol Oncol.
21:611–619. 2004.
|
|
15.
|
Kaya M, Wada T, Nagoya S, Sasaki M,
Matsumura T and Yamashita T: The level of vascular endothelial
growth factor as a predictor of a poor prognosis in osteosarcoma. J
Bone Joint Surg Br. 91:784–788. 2009.
|
|
16.
|
Mantadakis E, Kim G, Reisch J, et al: Lack
of prognostic significance of intratumoral angiogenesis in
nonmetastatic osteosarcoma. J Pediatr Hematol Oncol. 23:286–289.
2001.
|
|
17.
|
Ek ET, Ojaimi J, Kitagawa Y and Choong PF:
Does the degree of intratumoural microvessel density and VEGF
expression have prognostic significance in osteosarcoma? Oncol Rep.
16:17–23. 2006.
|
|
18.
|
Ek ET, Ojaimi J, Kitagawa Y and Choong PF:
Outcome of patients with osteosarcoma over 40 years of age: is
angiogenesis a marker of survival? Int Semin Surg Oncol.
3:72006.
|
|
19.
|
Kreuter M, Bieker R, Bielack SS, et al:
Prognostic relevance of increased angiogenesis in osteosarcoma.
Clin Cancer Res. 10:8531–8537. 2004.
|
|
20.
|
Ayala G, Liu C, Nicosia R, Horowitz S and
Lackman R: Microvasculature and VEGF expression in cartilaginous
tumors. Hum Pathol. 31:341–346. 2000.
|
|
21.
|
McGough RL, Aswad BI and Terek RM:
Pathologic neovascularization in cartilage tumors. Clin Orthop
Relat Res. 397:76–82. 2002.
|
|
22.
|
McGough RL, Lin C, Meitner P, Aswad BI and
Terek RM: Angiogenic cytokines in cartilage tumors. Clin Orthop
Relat Res. 397:62–69. 2002.
|
|
23.
|
Kalinski T, Sel S, Kouznetsova I, Röpke M
and Roessner A: Heterogeneity of angiogenesis and blood vessel
maturation in cartilage tumors. Pathol Res Pract. 205:339–345.
2009.
|
|
24.
|
Nakagawa SA, Lopes A, Lopes de Carvalho A,
et al: Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and
angiogenesis in chondrosarcoma and their relation to prognosis. J
Bone Joint Surg Am. 92:1738–1746. 2010.
|
|
25.
|
Riedel RF, Larrier N, Dodd L, Kirsch D,
Martinez S and Brigman BE: The clinical management of
chondrosarcoma. Curr Treat Options Oncol. 10:94–106. 2009.
|
